Filter News
Area of Research
- (-) Nuclear Science and Technology (5)
- Advanced Manufacturing (5)
- Biological Systems (1)
- Biology and Environment (73)
- Biology and Soft Matter (1)
- Clean Energy (137)
- Climate and Environmental Systems (2)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (7)
- Electricity and Smart Grid (3)
- Energy Sciences (1)
- Functional Materials for Energy (2)
- Fusion and Fission (9)
- Fusion Energy (2)
- Isotope Development and Production (1)
- Isotopes (10)
- Materials (107)
- Materials Characterization (1)
- Materials for Computing (18)
- Materials Under Extremes (1)
- Mathematics (1)
- National Security (25)
- Neutron Science (41)
- Quantum information Science (1)
- Sensors and Controls (2)
- Supercomputing (71)
- Transportation Systems (1)
News Type
News Topics
- (-) Biomedical (2)
- (-) Materials Science (3)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (11)
- Bioenergy (1)
- Computer Science (2)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (1)
- Fusion (8)
- Isotopes (5)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Physics (2)
- Space Exploration (5)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.